Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies

P Maggi, M Absinta, M Grammatico, L. Vuolo, G Emmi, G Carlucci, G Spagni, A Barilaro, AM Repice, L Emmi, Domenico Prisco, V Martinelli, R Scotti, N Sadeghi, G Perrotta, P Sati, B Dachy, DS Reich, M Filippi, L Massacesi

Research output: Contribution to journalArticle

Abstract

Objectives: In multiple sclerosis (MS), magnetic resonance imaging (MRI) is a sensitive tool for detecting white matter lesions, but its diagnostic specificity is still suboptimal; ambiguous cases are frequent in clinical practice. Detection of perivenular lesions in the brain (the “central vein sign”) improves the pathological specificity of MS diagnosis, but comprehensive evaluation of this MRI biomarker in MS-mimicking inflammatory and/or autoimmune diseases, such as central nervous system (CNS) inflammatory vasculopathies, is lacking. In a multicenter study, we assessed the frequency of perivenular lesions in MS versus systemic autoimmune diseases with CNS involvement and primary angiitis of the CNS (PACNS). Methods: In 31 patients with inflammatory CNS vasculopathies and 52 with relapsing–remitting MS, 3-dimensional T2*-weighted and T2–fluid-attenuated inversion recovery images were obtained during a single MRI acquisition after gadolinium injection. For each lesion, the central vein sign was evaluated according to consensus guidelines. For each patient, lesion count, volume, and brain location, as well as fulfillment of dissemination in space MRI criteria, were assessed. Results: MS showed higher frequency of perivenular lesions (median = 88%) than did inflammatory CNS vasculopathies (14%), without overlap between groups or differences between 3T and 1.5T MRI. Among inflammatory vasculopathies, Behçet disease showed the highest median frequency of perivenular lesions (34%), followed by PACNS (14%), antiphospholipid syndromes (12%), Sjögren syndrome (11%), and systemic lupus erythematosus (0%). When a threshold of 50% perivenular lesions was applied, central vein sign discriminated MS from inflammatory vasculopathies with a diagnostic accuracy of 100%. Interpretation: The central vein sign differentiates inflammatory CNS vasculopathies from MS at standard clinical magnetic field strengths. Ann Neurol 2018;83:283–294. © 2018 The Authors Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association
Original languageEnglish
Pages (from-to)283-294
Number of pages12
JournalAnnals of Neurology
Volume83
Issue number2
DOIs
Publication statusPublished - 2018

Fingerprint

Multiple Sclerosis
Veins
Central Nervous System
Magnetic Resonance Imaging
Autoimmune Diseases
Central Nervous System Vasculitis
Antiphospholipid Syndrome
Gadolinium
Brain
Magnetic Fields
Neurology
Vasculitis
Systemic Lupus Erythematosus
Multicenter Studies
Biomarkers
Guidelines
Injections

Cite this

Maggi, P., Absinta, M., Grammatico, M., Vuolo, L., Emmi, G., Carlucci, G., ... Massacesi, L. (2018). Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Annals of Neurology, 83(2), 283-294. https://doi.org/10.1002/ana.25146

Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. / Maggi, P; Absinta, M; Grammatico, M; Vuolo, L.; Emmi, G; Carlucci, G; Spagni, G; Barilaro, A; Repice, AM; Emmi, L; Prisco, Domenico; Martinelli, V; Scotti, R; Sadeghi, N; Perrotta, G; Sati, P; Dachy, B; Reich, DS; Filippi, M; Massacesi, L.

In: Annals of Neurology, Vol. 83, No. 2, 2018, p. 283-294.

Research output: Contribution to journalArticle

Maggi, P, Absinta, M, Grammatico, M, Vuolo, L, Emmi, G, Carlucci, G, Spagni, G, Barilaro, A, Repice, AM, Emmi, L, Prisco, D, Martinelli, V, Scotti, R, Sadeghi, N, Perrotta, G, Sati, P, Dachy, B, Reich, DS, Filippi, M & Massacesi, L 2018, 'Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies', Annals of Neurology, vol. 83, no. 2, pp. 283-294. https://doi.org/10.1002/ana.25146
Maggi, P ; Absinta, M ; Grammatico, M ; Vuolo, L. ; Emmi, G ; Carlucci, G ; Spagni, G ; Barilaro, A ; Repice, AM ; Emmi, L ; Prisco, Domenico ; Martinelli, V ; Scotti, R ; Sadeghi, N ; Perrotta, G ; Sati, P ; Dachy, B ; Reich, DS ; Filippi, M ; Massacesi, L. / Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. In: Annals of Neurology. 2018 ; Vol. 83, No. 2. pp. 283-294.
@article{325f3aec051545b8978c36d8d86ac20a,
title = "Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies",
abstract = "Objectives: In multiple sclerosis (MS), magnetic resonance imaging (MRI) is a sensitive tool for detecting white matter lesions, but its diagnostic specificity is still suboptimal; ambiguous cases are frequent in clinical practice. Detection of perivenular lesions in the brain (the “central vein sign”) improves the pathological specificity of MS diagnosis, but comprehensive evaluation of this MRI biomarker in MS-mimicking inflammatory and/or autoimmune diseases, such as central nervous system (CNS) inflammatory vasculopathies, is lacking. In a multicenter study, we assessed the frequency of perivenular lesions in MS versus systemic autoimmune diseases with CNS involvement and primary angiitis of the CNS (PACNS). Methods: In 31 patients with inflammatory CNS vasculopathies and 52 with relapsing–remitting MS, 3-dimensional T2*-weighted and T2–fluid-attenuated inversion recovery images were obtained during a single MRI acquisition after gadolinium injection. For each lesion, the central vein sign was evaluated according to consensus guidelines. For each patient, lesion count, volume, and brain location, as well as fulfillment of dissemination in space MRI criteria, were assessed. Results: MS showed higher frequency of perivenular lesions (median = 88{\%}) than did inflammatory CNS vasculopathies (14{\%}), without overlap between groups or differences between 3T and 1.5T MRI. Among inflammatory vasculopathies, Beh{\cc}et disease showed the highest median frequency of perivenular lesions (34{\%}), followed by PACNS (14{\%}), antiphospholipid syndromes (12{\%}), Sj{\"o}gren syndrome (11{\%}), and systemic lupus erythematosus (0{\%}). When a threshold of 50{\%} perivenular lesions was applied, central vein sign discriminated MS from inflammatory vasculopathies with a diagnostic accuracy of 100{\%}. Interpretation: The central vein sign differentiates inflammatory CNS vasculopathies from MS at standard clinical magnetic field strengths. Ann Neurol 2018;83:283–294. {\circledC} 2018 The Authors Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association",
author = "P Maggi and M Absinta and M Grammatico and L. Vuolo and G Emmi and G Carlucci and G Spagni and A Barilaro and AM Repice and L Emmi and Domenico Prisco and V Martinelli and R Scotti and N Sadeghi and G Perrotta and P Sati and B Dachy and DS Reich and M Filippi and L Massacesi",
year = "2018",
doi = "10.1002/ana.25146",
language = "English",
volume = "83",
pages = "283--294",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies

AU - Maggi, P

AU - Absinta, M

AU - Grammatico, M

AU - Vuolo, L.

AU - Emmi, G

AU - Carlucci, G

AU - Spagni, G

AU - Barilaro, A

AU - Repice, AM

AU - Emmi, L

AU - Prisco, Domenico

AU - Martinelli, V

AU - Scotti, R

AU - Sadeghi, N

AU - Perrotta, G

AU - Sati, P

AU - Dachy, B

AU - Reich, DS

AU - Filippi, M

AU - Massacesi, L

PY - 2018

Y1 - 2018

N2 - Objectives: In multiple sclerosis (MS), magnetic resonance imaging (MRI) is a sensitive tool for detecting white matter lesions, but its diagnostic specificity is still suboptimal; ambiguous cases are frequent in clinical practice. Detection of perivenular lesions in the brain (the “central vein sign”) improves the pathological specificity of MS diagnosis, but comprehensive evaluation of this MRI biomarker in MS-mimicking inflammatory and/or autoimmune diseases, such as central nervous system (CNS) inflammatory vasculopathies, is lacking. In a multicenter study, we assessed the frequency of perivenular lesions in MS versus systemic autoimmune diseases with CNS involvement and primary angiitis of the CNS (PACNS). Methods: In 31 patients with inflammatory CNS vasculopathies and 52 with relapsing–remitting MS, 3-dimensional T2*-weighted and T2–fluid-attenuated inversion recovery images were obtained during a single MRI acquisition after gadolinium injection. For each lesion, the central vein sign was evaluated according to consensus guidelines. For each patient, lesion count, volume, and brain location, as well as fulfillment of dissemination in space MRI criteria, were assessed. Results: MS showed higher frequency of perivenular lesions (median = 88%) than did inflammatory CNS vasculopathies (14%), without overlap between groups or differences between 3T and 1.5T MRI. Among inflammatory vasculopathies, Behçet disease showed the highest median frequency of perivenular lesions (34%), followed by PACNS (14%), antiphospholipid syndromes (12%), Sjögren syndrome (11%), and systemic lupus erythematosus (0%). When a threshold of 50% perivenular lesions was applied, central vein sign discriminated MS from inflammatory vasculopathies with a diagnostic accuracy of 100%. Interpretation: The central vein sign differentiates inflammatory CNS vasculopathies from MS at standard clinical magnetic field strengths. Ann Neurol 2018;83:283–294. © 2018 The Authors Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association

AB - Objectives: In multiple sclerosis (MS), magnetic resonance imaging (MRI) is a sensitive tool for detecting white matter lesions, but its diagnostic specificity is still suboptimal; ambiguous cases are frequent in clinical practice. Detection of perivenular lesions in the brain (the “central vein sign”) improves the pathological specificity of MS diagnosis, but comprehensive evaluation of this MRI biomarker in MS-mimicking inflammatory and/or autoimmune diseases, such as central nervous system (CNS) inflammatory vasculopathies, is lacking. In a multicenter study, we assessed the frequency of perivenular lesions in MS versus systemic autoimmune diseases with CNS involvement and primary angiitis of the CNS (PACNS). Methods: In 31 patients with inflammatory CNS vasculopathies and 52 with relapsing–remitting MS, 3-dimensional T2*-weighted and T2–fluid-attenuated inversion recovery images were obtained during a single MRI acquisition after gadolinium injection. For each lesion, the central vein sign was evaluated according to consensus guidelines. For each patient, lesion count, volume, and brain location, as well as fulfillment of dissemination in space MRI criteria, were assessed. Results: MS showed higher frequency of perivenular lesions (median = 88%) than did inflammatory CNS vasculopathies (14%), without overlap between groups or differences between 3T and 1.5T MRI. Among inflammatory vasculopathies, Behçet disease showed the highest median frequency of perivenular lesions (34%), followed by PACNS (14%), antiphospholipid syndromes (12%), Sjögren syndrome (11%), and systemic lupus erythematosus (0%). When a threshold of 50% perivenular lesions was applied, central vein sign discriminated MS from inflammatory vasculopathies with a diagnostic accuracy of 100%. Interpretation: The central vein sign differentiates inflammatory CNS vasculopathies from MS at standard clinical magnetic field strengths. Ann Neurol 2018;83:283–294. © 2018 The Authors Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association

U2 - 10.1002/ana.25146

DO - 10.1002/ana.25146

M3 - Article

VL - 83

SP - 283

EP - 294

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 2

ER -